IL140420A0 - Methods and transdermal compositions for pain relief - Google Patents
Methods and transdermal compositions for pain reliefInfo
- Publication number
- IL140420A0 IL140420A0 IL14042099A IL14042099A IL140420A0 IL 140420 A0 IL140420 A0 IL 140420A0 IL 14042099 A IL14042099 A IL 14042099A IL 14042099 A IL14042099 A IL 14042099A IL 140420 A0 IL140420 A0 IL 140420A0
- Authority
- IL
- Israel
- Prior art keywords
- methods
- pain relief
- transdermal compositions
- transdermal
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/106,684 US6290986B1 (en) | 1996-10-24 | 1998-06-29 | Method and composition for transdermal administration of pharmacologic agents |
| US12290399P | 1999-03-05 | 1999-03-05 | |
| PCT/US1999/014653 WO2000000120A1 (en) | 1998-06-29 | 1999-06-29 | Methods and transdermal compositions for pain relief |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL140420A0 true IL140420A0 (en) | 2002-02-10 |
Family
ID=26803907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14042099A IL140420A0 (en) | 1998-06-29 | 1999-06-29 | Methods and transdermal compositions for pain relief |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1093348A4 (en) |
| JP (1) | JP2002519310A (en) |
| KR (1) | KR20010078754A (en) |
| CN (1) | CN1331576A (en) |
| AU (1) | AU4841599A (en) |
| BG (1) | BG105175A (en) |
| BR (1) | BR9912508A (en) |
| CA (1) | CA2335837A1 (en) |
| HR (1) | HRP20000905A2 (en) |
| HU (1) | HUP0102728A3 (en) |
| ID (1) | ID28213A (en) |
| IL (1) | IL140420A0 (en) |
| MX (1) | MXPA00012767A (en) |
| NO (1) | NO20006604L (en) |
| PL (1) | PL345216A1 (en) |
| SK (1) | SK20012000A3 (en) |
| TR (1) | TR200003801T2 (en) |
| WO (1) | WO2000000120A1 (en) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6572880B2 (en) * | 1996-10-24 | 2003-06-03 | Pharmaceutical Applications Associates Llc | Methods and transdermal compositions for pain relief |
| JP2001526648A (en) | 1997-04-22 | 2001-12-18 | コセンシス・インコーポレイテッド | Semicarbazones and thiosemicarbazones substituted with carbocycles and heterocycles, and uses thereof |
| EP1632234B1 (en) * | 1999-07-01 | 2007-06-13 | Pharmacia & Upjohn Company LLC | (S,S)-reboxetine for treating chronic fatigue syndrome |
| WO2001001973A2 (en) | 1999-07-01 | 2001-01-11 | Pharmacia & Upjohn Company | Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| AU1261501A (en) * | 1999-12-06 | 2001-06-18 | Stanley L. Gore | Compositions and methods for intranasal delivery of active agents to the brain |
| IN191512B (en) * | 2000-01-21 | 2003-12-06 | Panacea Biotech | |
| DE10032132A1 (en) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition |
| DE10042412B4 (en) * | 2000-08-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | Transceiver for bus subscriber of bus system of building system engineering, has two wires, where microcontroller is connected with receiver unit over connection on one hand, which is connected to two wires of bus system |
| US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| CA2810477C (en) | 2002-12-13 | 2013-09-17 | Durect Corporation | Oral drug delivery system |
| JP2005154368A (en) * | 2003-11-27 | 2005-06-16 | Teikoku Seiyaku Co Ltd | Analgesic agent for neuropathic pain containing disopyramide |
| JP4807721B2 (en) * | 2004-01-29 | 2011-11-02 | 株式会社 メドレックス | Anti-inflammatory analgesic topical |
| SI2767292T1 (en) | 2004-09-17 | 2017-01-31 | Durect Corporation | Sustained Local Anesthetic Composition Containing SAIB |
| US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| JP2007308403A (en) * | 2006-05-17 | 2007-11-29 | Kenji Yoshida | Skin care preparation |
| KR100880748B1 (en) * | 2006-08-29 | 2009-02-02 | 정헌택 | Pharmaceutical composition containing demethoxycurcumin to prevent restenosis |
| ES2388355T3 (en) | 2006-11-03 | 2012-10-11 | Durect Corporation | Transdemic delivery systems comprising bupivacaine |
| US9511016B2 (en) * | 2007-06-12 | 2016-12-06 | Epicentrx, Inc. | Topical composition for treating pain |
| EP3326621A1 (en) | 2007-12-06 | 2018-05-30 | Durect Corporation | Oral pharmaceutical dosage forms |
| US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
| KR101237927B1 (en) * | 2009-05-07 | 2013-03-04 | (주)문엔제이 | Pharmaceutical composition for preventing or treating neuronal damage and neurological disorders |
| US8491927B2 (en) * | 2009-12-02 | 2013-07-23 | Nimble Epitech, Llc | Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor |
| AU2014233453A1 (en) | 2013-03-15 | 2015-10-01 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| CN108472253A (en) * | 2014-02-11 | 2018-08-31 | 雷迪博士实验室有限公司 | The parenteral composi of celecoxib |
| CN113164384A (en) | 2018-10-26 | 2021-07-23 | 维拉莫有限公司 | Mucoadhesive gel compositions |
| CA3167217A1 (en) | 2020-01-13 | 2021-07-22 | Durect Corporation | Sustained release drug delivery systems with reduced impurities and related methods |
| FR3108841B1 (en) * | 2020-04-06 | 2023-11-03 | Algotherapeutix | TOPICAL PHARMACEUTICAL COMPOSITION IN AQUEOUS GEL FORM COMPRISING AT LEAST AMITRIPTYLINE |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4395420A (en) * | 1981-12-09 | 1983-07-26 | Bernstein Joel E | Method and composition for treating pruritis |
| SI9300468A (en) * | 1992-10-14 | 1994-06-30 | Hoffmann La Roche | Injectable composition for the sustained release of biologically active compounds |
| GB9315856D0 (en) * | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
| US5654337A (en) * | 1995-03-24 | 1997-08-05 | II William Scott Snyder | Topical formulation for local delivery of a pharmaceutically active agent |
| US5837289A (en) * | 1996-07-23 | 1998-11-17 | Grasela; John C. | Transdermal delivery of medications using a combination of penetration enhancers |
| US5885597A (en) * | 1997-10-01 | 1999-03-23 | Medical Research Industries,Inc. | Topical composition for the relief of pain |
-
1999
- 1999-06-29 EP EP99932017A patent/EP1093348A4/en not_active Withdrawn
- 1999-06-29 KR KR1020007014985A patent/KR20010078754A/en not_active Application Discontinuation
- 1999-06-29 TR TR2000/03801T patent/TR200003801T2/en unknown
- 1999-06-29 ID IDW20010231A patent/ID28213A/en unknown
- 1999-06-29 AU AU48415/99A patent/AU4841599A/en not_active Abandoned
- 1999-06-29 IL IL14042099A patent/IL140420A0/en unknown
- 1999-06-29 WO PCT/US1999/014653 patent/WO2000000120A1/en not_active Application Discontinuation
- 1999-06-29 HU HU0102728A patent/HUP0102728A3/en unknown
- 1999-06-29 CN CN99810055A patent/CN1331576A/en active Pending
- 1999-06-29 MX MXPA00012767A patent/MXPA00012767A/en unknown
- 1999-06-29 SK SK2001-2000A patent/SK20012000A3/en unknown
- 1999-06-29 BR BR9912508-0A patent/BR9912508A/en not_active Application Discontinuation
- 1999-06-29 JP JP2000556706A patent/JP2002519310A/en active Pending
- 1999-06-29 PL PL99345216A patent/PL345216A1/en unknown
- 1999-06-29 CA CA002335837A patent/CA2335837A1/en not_active Abandoned
-
2000
- 2000-12-22 NO NO20006604A patent/NO20006604L/en not_active Application Discontinuation
- 2000-12-28 HR HR20000905A patent/HRP20000905A2/en not_active Application Discontinuation
-
2001
- 2001-01-24 BG BG105175A patent/BG105175A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000000120A9 (en) | 2000-03-30 |
| KR20010078754A (en) | 2001-08-21 |
| PL345216A1 (en) | 2001-12-03 |
| MXPA00012767A (en) | 2002-08-09 |
| BG105175A (en) | 2001-11-30 |
| TR200003801T2 (en) | 2001-06-21 |
| NO20006604L (en) | 2001-02-28 |
| HUP0102728A3 (en) | 2002-12-28 |
| WO2000000120A1 (en) | 2000-01-06 |
| BR9912508A (en) | 2001-05-02 |
| HUP0102728A2 (en) | 2002-03-28 |
| EP1093348A4 (en) | 2003-07-16 |
| NO20006604D0 (en) | 2000-12-22 |
| AU4841599A (en) | 2000-01-17 |
| ID28213A (en) | 2001-05-10 |
| CA2335837A1 (en) | 2000-01-06 |
| CN1331576A (en) | 2002-01-16 |
| HRP20000905A2 (en) | 2001-08-31 |
| SK20012000A3 (en) | 2001-08-06 |
| EP1093348A1 (en) | 2001-04-25 |
| JP2002519310A (en) | 2002-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0102728A3 (en) | Methods and transdermal compositions for pain relief | |
| AU2002234192A8 (en) | Methods and transdermal compositions for pain relief | |
| AU2024500A (en) | Intraoral electromuscular stimulation device and method | |
| AU6872498A (en) | Method and composition for skin treatment | |
| HUP0103621A3 (en) | Fentanyl composition for the treatment of acute pain | |
| EP1065978A4 (en) | Implantable therapeutic device and method | |
| AU5439996A (en) | Compositions and methods for treating pain | |
| PL329211A1 (en) | Pain relieving method | |
| HK1031174A1 (en) | Compositions and methods for treating diabetes | |
| AU7696098A (en) | Substance p inhibitors in combination with nmda-blockers for treating pain | |
| AU3877900A (en) | Compositions and methods for preventing and treating sexual dysfunctions | |
| AU3784999A (en) | Methods for treatment of pain | |
| AU6056500A (en) | Process and composition for temporarily suppressing pain | |
| IL124650A0 (en) | Methods and therapeutic compositions for treating cancer | |
| PL329217A1 (en) | Pain relieving method | |
| AU3204899A (en) | Hair treatment composition and method | |
| EP1007041A4 (en) | Composition for treating pain | |
| AU2420101A (en) | Method and composition for the treatment of pain | |
| AU5169200A (en) | Methods and compositions for treating breakthrough pain | |
| AU7247898A (en) | Composition for treating pain | |
| IL150202A0 (en) | Method and composition for the treatment of pain | |
| EP1112250A4 (en) | Therapeutic compounds and methods | |
| AU5097099A (en) | Methods and compositions for cancer treatment | |
| AU5768300A (en) | Pain relief composition and method of relieving pain | |
| GB9909918D0 (en) | Pain relief |